Please note: Work is currently underway to update content available on this site.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Publication #7201
Reference
MSAN(2020)116
Name
Rifadin® (rifampicin) 100mg/5ml oral suspension
Categories
Scottish Government
Organization
Scottish Government Health and Social Care Directorates
Keywords
NHS
SCOTLAND
DRUGS
SAFETY
RISKS
PHARMACEUTICAL INDUSTRY
DRUG THERAPY
PHARMACEUTICAL SERVICES
SUPPLIES
Description
Sanofi have limited supplies of Rifadin® 100mg/5ml oral suspension with resupply expected w/c 18 January 2021. Until w/c 18 January 2021, supplies will only remain available to primary care. Hospital pharmacies will need to order unlicensed supplies from Specialist Importers or Specials Manufacturers if current stock holding is insufficient to last until the resupply date. Rifampicin 150mg and 300mg capsules remain available.
Contact Name
Contact Email
Contact Address
Created
2020-12-29 00:00:00
Click to go back to homepage